For over 20 years Xstrahl has been shaping the development of superficial and orthovoltage therapies.
Xstrahl’s superficial and orthovoltage radiotherapy systems are the choice of leading clinical centres across the world to deliver effective treatments for skin cancer and other dermatological disorders, as well as providing palliation for secondary lesions.
Xstrahl Medical provides an unsurpassed level of service from initial specification and suite design through to installation and ongoing training, education and maintenance. The Xstrahl team’s unique in-depth understanding of the clinical environment and radiography techniques ensures an unrivalled level of clinical training to users of its products.
Responding to very real clinical need and drawing on the knowledge and expertise of healthcare professionals, we are committed to providing innovative radiotherapy solutions that deliver positive patient outcomes.
Xstrahl 100 and 150
The Xstrahl 100 and 150 X-ray therapy systems offer a low energy option for superficial treatment of clinical indications including: basal cell carcinoma, squamous cell carcinoma, keloid scars, dermatological conditions and mycosis fungoides. The higher energy range of the 150 X-ray system enables deeper skin lesions to be treated.
Xstrahl 200 and 300
The Xstrahl 200 and 300 X-ray therapy systems are also suitable for treating all the superficial conditions outlined above. The additional orthovoltage capability makes them ideal for providing palliative treatment and treatment of benign conditions including: inflammatory disorders, degenerative disorders and hypertrophic disorders.